Sign in
Active, not recruitingNo phase

Herpes Virus Infections in Kidney Transplant Patients

Key facts

Who runs it
Susanne Dam Nielsen, MD, DMSc
Where
Denmark5 sites in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
280 people enrolled
Started
1 Jan 2023
Expected to end
31 Dec 2030
Type of study
Observational
Record updated
12 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Kidney transplant recipient transplanted after 2019-01-01 OR on the kidney transplant waitlist
  • Has been offered Shingrix® vaccination

Who cannot take part

  • Lack of informed consent
  • Inability to understand the study information

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Kidney transplant recipients are at increased risk of infections, including Varicella-zoster virus (VZV) infections. Vaccination against VZV is routinely offered to all kidney transplant recipients and candidates in Denmark. In this exploratory observational study, the VZV specific immune response in kidney transplant candidates and recipients will be characterized at different time points in relation to transplantation, vaccination and infections. More knowledge on the immune reaction to transplantation, VZV vaccination and VZV infections may provide improved strategies for prevention and treatment of VZV infections in kidney transplant candidates and recipients.

The group in the trial

  • Kidney transplant patients

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Investigation of Kidney Transplant Patients for Antibodies and T-cells After Herpes Virus Vaccination and Infection
Publications
Record updated
12 August 2026